pancytopenia

DEFINITION of pancytopenia

pan-cyto--penia — Simultaneous reduction of all three major blood cell lines (red blood cells, white blood cells, and platelets) below normal reference ranges. Pancytopenia is not a diagnosis itself but a hematologic finding — a constellation of anemia (erythropenia), leukopenia (or specifically neutropenia), and thrombocytopenia occurring concurrently, reflecting globally impaired blood cell production or accelerated peripheral destruction. The most common mechanism is bone marrow failure, in which the marrow’s pluripotent stem cells are damaged, suppressed, or replaced, resulting in insufficient output of all three lineages. Major causes include aplastic anemia (autoimmune marrow destruction), myelodysplastic syndrome (MDS), infiltrative processes (leukemia, lymphoma, metastatic malignancy, granulomatous disease), nutritional deficiencies (B12, folate), medications/chemotherapy, sepsis, hypersplenism (sequestration), and paroxysmal nocturnal hemoglobinuria (PNH). Severity is graded by degree of cytopenias (Camitta criteria for aplastic anemia: severe = ANC <500, platelets <20K, reticulocytes <1%).

---

ETYMOLOGY of pancytopenia

greek

Component	Origin	Meaning
pan-	Greek πᾶν (pân)	“All,” “every,” “entire” — universal prefix
cyto-	Greek κύτος (kytos)	“Cell,” “hollow vessel” — referring to blood cells
-penia	Greek πενία (penía)	“Poverty,” “deficiency,” “lack” — from penēs (“needy”)

Literal construction: “Poverty of all cells.” The term is a compound Greek neologism coined in the early 20th century as hematology developed quantitative cell counting methods. The same suffix -penia appears in thrombocytopenia (platelet deficiency), leukopenia (white cell deficiency), and neutropenia (neutrophil deficiency). The prefix pan- also appears in pancreatitis (“all flesh” inflammation) and pandemic** (“all people”). First clinical use of pancytopenia is attributed to early 20th-century descriptions of aplastic anemia.

---

ALIASES / RELATED TERMS

Term	Root Breakdown	Meaning / Relationship
Trilineage cytopenia	tri- + lineage + cyto- + -penia	Synonym; emphasizes all three marrow cell lines affected
Aplastic anemia	a- + plasis + anemia	Most common cause; autoimmune bone marrow failure → pancytopenia
Anemia	an- + -emia	RBC/hemoglobin component of pancytopenia
Leukopenia	leuko- + -penia	WBC component of pancytopenia
neutropenia	neutro- + -penia	Specific WBC subset; drives infection risk
Thrombocytopenia	thrombocyto- + -penia	Platelet component; drives bleeding risk
Myelodysplastic syndrome	myelo- + dys- + -plasia	Clonal marrow disorder; major cause of pancytopenia in elderly
Hypersplenism	hyper- + splen- + -ism	Peripheral sequestration cause; spleen traps all cell lines
pancytopenia with myelophthisis	pan- + myelo- + phthisis	Marrow replaced by fibrosis, tumor, or granuloma
PNH (Paroxysmal Nocturnal Hemoglobinuria)	Acronym	Clonal GPI-deficient disorder closely associated with aplastic anemia/pancytopenia

---

🏥 CODING CONTEXT

📋 ICD-10-CM — Pancytopenia & Bone Marrow Failure

⚠️ Critical Coding Note: D61.818 (Other pancytopenia) is a manifestation/finding code — it should be used only when the underlying cause cannot be coded more specifically. When the etiology is known (e.g., drug-induced, aplastic anemia, MDS), code the underlying condition first, not D61.818. The ICD-10-CM tabular instructs to code the underlying condition when pancytopenia is a feature of a classified disease.

Pancytopenia — Direct Codes

ICD-10-CM Code	Description
D61.810	Antineoplastic chemotherapy induced pancytopenia (code also the neoplasm and adverse effect T45.1x5A)
D61.818	Other pancytopenia (use when etiology not classifiable to a more specific code)

Aplastic Anemia — Common Etiology Codes (D61)

ICD-10-CM Code	Description
D61.01	Constitutional (pure) red blood cell aplasia — Diamond-Blackfan anemia
D61.09	Other constitutional aplastic anemia (Fanconi anemia)
D61.1	Drug-induced aplastic anemia (requires additional T-code for drug)
D61.2	Aplastic anemia due to other external agents (requires additional T-code)
D61.3	Idiopathic aplastic anemia
D61.9	Aplastic anemia, unspecified

Component Cytopenia Codes (when coded separately)

ICD-10-CM Code	Description
D64.9	Anemia, unspecified (RBC component)
D69.6	Thrombocytopenia, unspecified (platelet component)
D70.9	Neutropenia, unspecified (WBC component)
D72.819	Decreased white blood cell count, unspecified

Associated / Underlying Condition Codes

ICD-10-CM Code	Description
D46.9	Myelodysplastic syndrome, unspecified (major cause in elderly)
D59.5	Paroxysmal nocturnal hemoglobinuria (PNH) (clonal disorder with aplastic anemia overlap)
D61.82	Myelophthisis (marrow replaced by fibrosis/tumor/granuloma)
D61.89	Other specified aplastic anemias and bone marrow failure syndromes

---

🔧 CPT Codes — Workup & Treatment

CPT Code	Description
85025	CBC with differential — primary diagnostic screen for pancytopenia
85027	CBC without differential
85060	Blood smear interpretation by physician with written report
38220	Bone marrow aspiration(s) (alone — do not report with 38222)
38221	Bone marrow biopsy(ies) (alone — do not report with 38222)
38222	Bone marrow biopsy(ies) and aspiration(s) (combined — do NOT report with 38220 or 38221)
88305	Level IV surgical pathology — bone marrow biopsy interpretation
86849	Unlisted immunology procedure (flow cytometry for PNH clone — GPI-anchor deficiency panel)
38240	Hematopoietic progenitor cell (HPC); allogeneic transplantation per donor
38241	Hematopoietic progenitor cell (HPC); autologous transplantation
96413	Chemotherapy administration; IV infusion, up to 1 hour (for ATG infusion)
96415	Chemotherapy administration; IV infusion, each additional hour

---

🏷️ Modifiers & Billing Guidance

Modifier	Usage in Pancytopenia Context
-59	Distinct procedural service — use when bone marrow aspiration and biopsy are performed at separate sites or incisions (otherwise use 38222 combined code)
-26	Professional component — bone marrow interpretation (88305) when pathologist bills separately from facility
-TC	Technical component — facility bill for bone marrow processing/slides
-GC	Service performed in part by a resident under attending supervision

⚠️ NCCI / Bundling Note: 38222 (combined biopsy + aspiration) bundles 38220 and 38221 — billing all three at the same session through the same incision will result in denial. Use 38220 or 38221 only when a single procedure is performed alone. 88305 (pathology interpretation) is always separately billable and should be captured on every bone marrow case. When antineoplastic chemotherapy is the cause (D61.810), also code the adverse effect with T45.1X5A (adverse effect of antineoplastic drugs, initial encounter) and the underlying neoplasm.

---

🔗 HCC / Value-Based Care

D61.818 (Other pancytopenia) does not directly map to an HCC. However, the underlying conditions driving pancytopenia carry significant HCC weight:

• D46.x (MDS) → HCC 47 (Disorders of Immunity) in some models
• Aplastic anemia (D61.3, D61.9) → HCC 46 (Coagulation Defects and Other Specified Hematological Disorders)
• Leukemia/lymphoma as the cause → HCC 8/9/10 (highest-weight hematologic malignancy HCCs)
• Documenting the etiology of pancytopenia is therefore essential — “pancytopenia due to MDS” vs. “pancytopenia, unspecified” has material RAF/HCC implications

---

DERIVATIONS of pancytopenia

TABLE definition AS Definition
FROM #medterm 
WHERE length(filter(roots, (word) => econtains(this.roots, word))) > 0 AND file.name != this.file.name
SORT file.name ASC

---

Query functionality

TABLE definition AS Definition
FROM #medterm 
WHERE length(filter(definition, (word) => econtains(this.definition, word))) > 0 AND file.name != this.file.name

Med roots Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms